Further evaluation of the correlation between S100s and HCC with multiple clinical statuses showed that some S100 family members may interact with a variety of different signaling pathways and significantly contribute to the pathophysiology of HCC. This evidence concerns the gene S100A1 and hepatocellular carcinoma.